版本:
中国

BRIEF-Paratek Pharma announces new microbiology data findings

April 24 Paratek Pharmaceuticals Inc:

* New microbiology data from Paratek Pharmaceuticals show omadacycline effective against most common skin infections and pathogens, including MRSA

* Also presented full clinical efficacy, safety and tolerability results from study, which is known as oasis

* Paratek Pharma - full results from oasis study demonstrate efficacy, safety of omadacycline versus linezolid in acute bacterial skin, skin structure infections Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐